New Key Statistics Module, Z-Score and F-Score
NAS:CHRS Key Ratios
| Market Cap $ M | 83.03 |
| Enterprise Value $ M | 188.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.30 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 5.76 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 308.00 |
| EPS (TTM) $ | -0.40 |
| Beneish M-Score | -2.38 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 24.76 |
| EV-to-EBITDA | 15.37 |
| PEG | -- |
| Shares Outstanding M | 115.21 |
| Net Margin (%) | -9.52 |
| Operating Margin % | -53.21 |
| Pre-tax Margin (%) | -9.65 |
| Quick Ratio | 1.07 |
| Current Ratio | 1.21 |
| ROA % (ttm) | -4.70 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -74.01 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.36 |
CHRS Number of Guru Trades
CHRS Volume of Guru Trades
Gurus Latest Trades with NAS:CHRS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CHRS is held by these investors
Total 1
Coherus BioSciences Inc Insider Transactions
No Available Data
News about NAS:CHRS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers